FDA's MedWatch Safety Alerts: September 2009

FDA's MedWatch Safety Alerts: September 2009

On this page:

Recall: Children's and Infants' Tylenol Oral Suspension Products
Choking Hazard for Lifeline Pendant Personal Help Buttons
Warning About Topical Ibuprofen Drugs
Stronger Warnings for TNF Blockers
Early Communication on Safety of Alli and Xenical
Stolen Levemir Insulin May Be Dangerous
Intelence and Severe Skin Reactions
Tysabri (Natalizumab) and Brain Infection


After the Food and Drug Administration (FDA) approves a product and it is on the market, FDA continues to monitor unexpected and undesirable side effects (adverse events) of that product.

Health care professionals and consumers may report side effects, product quality problems, product use errors, or therapeutic failure with the use of medical products to FDA's MedWatch Adverse Event Reporting program either online, by regular mail, by fax, or by phone.

abrir aquí para acceder al documento FDA completo (extenso):
FDA's MedWatch Safety Alerts: September 2009